Results 31 to 40 of about 178,362 (241)

An Efficient Synthesis of Novel Dextran-Arsenite Nanoparticles intended for Potential Antitumor Drug Material [PDF]

open access: yesAnais da Academia Brasileira de Ciências, 2021
The functionalization of polysaccharides with synthetic nanopolymers has attracted great attention owing to the applications of this method in many industrial fields.
WEIBING LAN, SHAN CHEN, GUANGZAI NONG
doaj   +1 more source

Arsenic trioxide downregulates cancer procoagulant activity in MCF-7 and WM-115 cell lines in vitro [PDF]

open access: yes, 2015
© 2015 Termedia Sp. z o. o. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing ...
Gizelska, Katarzyna   +3 more
core   +2 more sources

PML isoforms in response to arsenic: high-resolution analysis of PML body structure and degradation [PDF]

open access: yes, 2014
Arsenic is a clinically effective treatment for acute promyelocytic leukaemia (APL) in which the promyelocytic leukaemia (PML) protein is fused to retinoic receptor alpha (RARα).
Beech   +34 more
core   +4 more sources

Arsenic Primes Human Bone Marrow CD34+ Cells for Erythroid Differentiation

open access: yesBioinorganic Chemistry and Applications, 2015
Arsenic trioxide exhibits therapeutic effects on certain blood malignancies, at least partly by modulating cell differentiation. Previous in vitro studies in human hematopoietic progenitor cells have suggested that arsenic may inhibit erythroid ...
Yuanyuan Zhang   +5 more
doaj   +1 more source

Successful treatment of acute promyelocytic leukemia in a patient under hemodialysis with arsenic trioxide

open access: yesClinical Case Reports, 2021
A man with chronic kidney disease (CKD) under hemodialysis was diagnosed with acute promyelocytic leukemia (APL). He received arsenic trioxide as a single agent and achieved complete molecular remission without severe adverse events.
Akiko Hashimoto   +3 more
doaj   +1 more source

Molecular mechanism of oprozomib synergistic with arsenic trioxide in inhibiting proliferation of acute promyeloid leukemia cells

open access: yesDi-san junyi daxue xuebao, 2022
Objective To investigate the molecular mechanism of oprozomib synergistically acting with arsenic trioxide in inhibiting the proliferation of acute promyeloid leukemia cells.
DING Xin   +4 more
doaj   +1 more source

Arsenic speciation in saliva of acute promyelocytic leukemia patients undergoing arsenic trioxide treatment [PDF]

open access: yes, 2013
Arsenic trioxide has been successfully used as a therapeutic in the treatment of acute promyelocytic leukemia (APL). Detailed monitoring of the therapeutic arsenic and its metabolites in various accessible specimens of APL patients can contribute to ...
Baowei Chen   +6 more
core   +1 more source

Oral arsenic trioxide, all‐trans retinoic acid, and ascorbic acid maintenance after first complete remission in acute promyelocytic leukemia: Long‐term results and unique prognostic indicators

open access: yesCancer, 2020
The role of arsenic trioxide (As2O3) in the maintenance of first complete remission (CR1) in acute promyelocytic leukemia (APL) is unclear.
H. Gill   +4 more
semanticscholar   +1 more source

Effects of spirulina as a functional ingredient in arsenic-induced broiler diet on growth performance and hematobiochemical parameters

open access: yesJournal of Advanced Veterinary and Animal Research, 2022
Objectives: The purpose of this research was to look into the impacts after the implication of feeding broiler chickens with spirulina in arsenic-incited toxicities.
Md. Mowdudul Hasan Talha   +5 more
doaj   +1 more source

E2F1 Downregulation by Arsenic Trioxide in Lung Adenocarcinoma [PDF]

open access: yes, 2014
Lung cancer is one of the most common cancers worldwide. Arsenic trioxide (ATO) has been approved by the U.S. Food and Drug Administration for the treatment of acute promyelocytic leukemia.
Ho, JCM   +4 more
core   +1 more source

Home - About - Disclaimer - Privacy